In line with its glocal vocation, MTM goes beyond the borders of Italy to participate in the next edition of the BIO International Convention in San Diego: MTM is, in fact, one of the 20 European companies admitted – as part of the promotional activities in support of internationalization promoted by the EIC program – Overseas Trade Fairs 2.0 – to participate in the BIO 2022 exhibition.

The U.S. event, which will be held June 13-16, 2022, in California (USA) at the San Diego Convention Center, involves more than 1,100 biotechnology companies, as well as academic institutions, biotechnology centers and other industry organizations from the United States and more than 30 countries. Back in attendance in this very edition, the event brings together a wide range of life sciences and their applications, including pharmaceutical research, bioproduction, genomics, the biofuel sphere, nanotechnology and cell therapy.

Within this global showcase, which includes several sessions and extraordinary networking opportunities with more than 16,000 participants from about 67 countries, the MTM Team will have the honor to present its latest project in the Med-Tech field: ROG (Real Organ Generation).

ROG is a software application that allows users to perform virtual surgery simulations. In particular, through a patented method of generating 3D images of pathological tissues, the software is able to digitize the organ under examination in its real state and size. Thus, leveraging Virtual Reality and Artificial Intelligence technologies, ROG can localize the exact location of pathologies and allows its users to interact with the organ, performing virtual surgical simulation activities.

So, starting from a fact so evident that it is now impossible to overlook, namely the fact that the future of healthcare is inexorably digital, as well as strongly marked by technology, MTM has decided to take its ROG project overseas. In fact, as mental and physical wellbeing becomes a higher priority, the demand for cutting-edge, more precise medical solutions is skyrocketing. For this reason, several innovative companies are aiming to become pioneers in the field, integrating advanced technologies to create new MedTech solutions. Therefore, at the upcoming BIO 2022, leading technology companies will showcase the most innovative healthcare and Med-Tech solutions designed to enable everyone to take care of their health.

As an innovative company strongly oriented towards the MedTech sector, MTM has also chosen to contribute to the future of healthcare with its ROG R&D project, with the aim of responding to the high demand for advanced technology with solutions capable of intercepting the existing gap within healthcare and medical solutions, in an extremely delicate field such as surgery.

MTM’s presence will be located within the European Pavillion – Exhibit Hall: 1911.